Alkermes is transitioning into an integrated neuroscience and sleep medicine company. Click here to see why ALKS stock is a ...

Equitable Holdings’ updated analyst work now points to a fair value estimate of $57.38 per share, a slight adjustment from the prior $57.46 target. This change sits alongside fresh research where some ...

Analog Devices is outperforming DAO peers in 2026, driven by industrial segment strength and robust ATE market exposure.

Q1 2026 Management View "This quarter reflects a company executing well against a clear strategy with strong momentum in ClearanceJobs and encouragingly early progress across our strategic initiatives ...